http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-1761746-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 |
| filingDate | 2004-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-1761746-B |
| titleOfInvention | Fusion constructs and being used for produces the purposes of the antibody that Fc receptor binding affinity and effector function improve |
| abstract | The present invention relates to field of glycosylation engineering of proteins.More particularly, the present invention relates to nucleic acid molecule, comprise fusion constructs, it has catalytic activity and the purposes in the glycosylation engineering of host cell thereof to produce the treatment characteristic with strengthening, and comprises the polypeptide of antibody with the effector functions of the Fc receptors bind strengthened and enhancing. |
| priorityDate | 2003-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1806.